These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

153 related articles for article (PubMed ID: 27403783)

  • 1. Onzetra Xsail--sumatriptan nasal powder.
    Med Lett Drugs Ther; 2016 Jul; 58(1499):92-3. PubMed ID: 27403783
    [No Abstract]   [Full Text] [Related]  

  • 2. AVP-825: a novel intranasal delivery system for low-dose sumatriptan powder in the treatment of acute migraine.
    Silberstein S
    Expert Rev Clin Pharmacol; 2017 Aug; 10(8):821-832. PubMed ID: 28605258
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Commentary.
    Rothrock JF
    Headache; 2011 Apr; 51(4):518-9. PubMed ID: 21457236
    [No Abstract]   [Full Text] [Related]  

  • 4. Sumatriptan iontophoretic transdermal system: a review of its use in patients with acute migraine.
    Garnock-Jones KP
    Drugs; 2013 Sep; 73(13):1483-90. PubMed ID: 23912626
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Breath-Powered Intranasal Sumatriptan Dry Powder.
    Tepper D
    Headache; 2016 Apr; 56(4):817-8. PubMed ID: 27092539
    [No Abstract]   [Full Text] [Related]  

  • 6. A review of clinical safety data for sumatriptan nasal powder administered by a breath powered exhalation delivery system in the acute treatment of migraine.
    Silberstein SD
    Expert Opin Drug Saf; 2018 Jan; 17(1):89-97. PubMed ID: 28994319
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Sumatriptan Nasal Powder: A Review in Acute Treatment of Migraine.
    Al-Salama ZT; Scott LJ
    Drugs; 2016 Oct; 76(15):1477-1484. PubMed ID: 27681528
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Choice of triptan in migraine].
    Salvesen R
    Tidsskr Nor Laegeforen; 2001 Nov; 121(29):3410-1. PubMed ID: 11826788
    [No Abstract]   [Full Text] [Related]  

  • 9. Clinical implications for breath-powered powder sumatriptan intranasal treatment.
    Tepper SJ
    Headache; 2013 Sep; 53(8):1341-9. PubMed ID: 23809006
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A sumatriptan patch (Zecuity) for migraine.
    Med Lett Drugs Ther; 2015 Nov; 57(1481):151-2. PubMed ID: 26529132
    [No Abstract]   [Full Text] [Related]  

  • 11. Faster Improvement in Migraine Pain Intensity and Migraine-Related Disability at Early Time Points with AVP-825 (Sumatriptan Nasal Powder Delivery System) versus Oral Sumatriptan: A Comparative Randomized Clinical Trial Across Multiple Attacks from the COMPASS Study.
    Lipton RB; McGinley JS; Shulman KJ; Wirth RJ; Buse DC
    Headache; 2017 Nov; 57(10):1570-1582. PubMed ID: 28880380
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Intranasal sumatriptan powder delivered by a novel breath-actuated bi-directional device for the acute treatment of migraine: A randomised, placebo-controlled study.
    Djupesland PG; Docekal P;
    Cephalalgia; 2010 Aug; 30(8):933-42. PubMed ID: 20656704
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Question 2: Does intranasal sumatriptan use relieve migraine in children and young people?
    Yong JW; Anand G
    Arch Dis Child; 2013 Jan; 98(1):82-4. PubMed ID: 23255042
    [No Abstract]   [Full Text] [Related]  

  • 14. Sumatriptan needle-free subcutaneous (Sumavel(®) DosePro™) approved for the acute treatment of migraine, with or without aura, and cluster headaches.
    Freitag FG
    Expert Rev Neurother; 2011 Apr; 11(4):481-90. PubMed ID: 21469920
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Intranasal sumatriptan for migraine in children.
    Goldman RD; Meckler GD
    Can Fam Physician; 2015 May; 61(5):435-7. PubMed ID: 25971759
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Drug-clinics. The drug of the month. Imitrex nasal spray (sumatriptan)].
    Scheen AJ
    Rev Med Liege; 1997 Sep; 52(9):610-2. PubMed ID: 9441347
    [No Abstract]   [Full Text] [Related]  

  • 17. Randomized, multicenter trial to assess the efficacy, safety and tolerability of a single dose of a novel AMPA receptor antagonist BGG492 for the treatment of acute migraine attacks.
    Gomez-Mancilla B; Brand R; Jürgens TP; Göbel H; Sommer C; Straube A; Evers S; Sommer M; Campos V; Kalkman HO; Hariry S; Pezous N; Johns D; Diener HC;
    Cephalalgia; 2014 Feb; 34(2):103-13. PubMed ID: 23963355
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Sumatriptan nasal spray 20mg: efficacy, tolerance and quality of life in migraine patients].
    Géraud G; Valette C
    Rev Neurol (Paris); 2000 Jul; 156(6-7):646-53. PubMed ID: 10891800
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Rapid absorption of sumatriptan powder and effects on glyceryl trinitrate model of headache following intranasal delivery using a novel bi-directional device.
    Luthringer R; Djupesland PG; Sheldrake CD; Flint A; Boeijinga P; Danjou P; Demazières A; Hewson G
    J Pharm Pharmacol; 2009 Sep; 61(9):1219-28. PubMed ID: 19703372
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A review of needle-free sumatriptan injection for rapid control of migraine.
    Rothrock JF; Freitag FG; Farr SJ; Smith EF
    Headache; 2013 Sep; 53 Suppl 2():21-33. PubMed ID: 24024600
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.